Evidence map›Paper›PMID 29468675›Full record

ArticleHealth services research2018

Market Competition and Health Outcomes in Hemodialysis.

Kevin F Erickson, Yuanchao Zheng, Vivian Ho, Wolfgang C Winkelmayer, Jay Bhattacharya, Glenn M Chertow

Abstract read
In one paragraph

Article in Health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Hemodialysis Facilities, Vascular Access Surgeons, and Central Venous Catheter Use: A Retrospective Cohort Study.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Safety-Net Care for Maintenance Dialysis in the United States.Journal of the American Society of Nephrology : JASN · 2020
    Article
  8. Observational
  9. Market Consolidation and Mortality in Patients Initiating Hemodialysis.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kevin F EricksonSection of Nephrology and Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, TX.ORCID 0000-0003-2164-609X
Yuanchao ZhengDivision of Nephrology, Stanford University School of Medicine, Palo Alto, CA.
Vivian HoHouston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX.
Wolfgang C WinkelmayerSection of Nephrology and Selzman Institute for Kidney Health, Baylor College of Medicine, Houston, TX.
Jay BhattacharyaCenter for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, CA.
Glenn M ChertowDivision of Nephrology, Stanford University School of Medicine, Palo Alto, CA.

Funding

TRAINING PROGRAM IN ACADEMIC NEPHROLOGYT32DK007357 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 1986 to 2022
$4.8M
Mentoring Patient-Oriented Clinical Investigators in NephrologyK24DK085446 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 2010 to 2022
$1.4M
The Effect of Provider Market Competition on Patient Health Outcomes in DialysisK23DK101693 · NIDDK · STANFORD UNIVERSITY · PI ERICKSON, KEVIN · 2014 to 2018
$888k
NIDDK NIH HHS K23 DK101693NIDDK NIH HHS K24 DK085446NIDDK NIH HHS T32 DK007357
6 · The paper itself

Abstract

objectiveTo examine whether market competition is associated with improved health outcomes in hemodialysis. DATA SOURCES: Secondary analysis of data from a national dialysis registry between 2001 and 2011. STUDY

designWe conducted one- and two-part linear regression models, using each hospital service area (HSA) as its own control, to examine the independent associations among market concentration and health outcomes. DATA COLLECTION: We selected cohorts of patients receiving in-center hemodialysis in the United States at the start of each calendar year. We used information about dialysis facility ownership and the location where patients received dialysis to measure an index of market concentration-the Hirschman-Herfindahl Index (HHI)-for HSA and year, which ranges from near zero (perfect competition) to one (monopoly). PRINCIPAL

findingsAn average reduction in HHI by 0.2 (one standard deviation in 2011) was associated with 2.9 fewer hospitalizations per 100 patient-years (95 percent CI, 0.4 to 5.4). If these findings were generalized to the entire in-center hemodialysis population, this would translate to 8,100 (95 percent CI 1,200 to 15,000) fewer hospitalizations in 2011. There was no association between change in market competition and mortality.

conclusionsMarket competition in dialysis may lead to improved health outcomes.

Indexed as

Economic CompetitionFemaleHumansMaleMiddle AgedRegistriesRenal DialysisUnited StatesCompetitiondialysishealth outcomes

Identifiers

PMID29468675
PMCPMC6153181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.